DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, individual leading pharmacogenomic testing service companies' market shares, ...
A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...
This article explores how biobanks, proteomics, and AI are enabling population-scale insights, earlier disease detection, and ...
The U.S. Aptamers Market is projected to grow from USD 1.49 Billion in 2025 to USD 11.90 Billion by 2035, while Europe is ...
The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.
Cole Schenewerk’s passion for credit card points and miles has led him around the globe. Following a career in corporate finance, he now helps others maximize the rewards they earn from their spending ...
Prodrugs are bioreversible derivatives of drug molecules that must undergo an enzymatic and/or chemical transformation in vivo to release the active parent drug, which can then exert its desired ...
The global biomarkers market is projected to grow to $112.1b by 2031, from $67.95b in 2026, due to expanding use in drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results